Ozempic is a diabetes medication that is often used off-label for weight loss
However, notably, the 3.0- and 4.5-mg dosage formulations were introduced to the market relatively recently in January 2021 in both countries
Eli Lilly must first submit a New Drug Application (NDA) to the FDA, receive approval, and then file a corresponding submission with Health Canada for review
This bill is a product of the work weve done through the interim on the Families and Children Committee, in the interim committee meetings as well as roundtable discussions with members of the cabinet, members of law enforcement, many interested parties, Wilson testified
Overweight and obesity are also widespread
Below are pragmatic protocols that mirror human clinical research